Two men from very different worlds are changing how Miami’s Latinx community accesses Prep — in a city where 5 percent of people are living with HIV. That's more than New York, L.A., or San Francisco.
"People are dying!" the Congresswoman said, calling on the CEO of Gilead to improve access to PrEP in order to end the HIV epidemic.
Prosecutors claim that Teva, Pfizer, Novartis, and Mylan, among others, schemed their way to higher profits.
The advocacy group is singlehandedly going against Gilead and the CDC to release its hold or PrEP.
Your diagnosis may seem overwhelming, but we can help you through it. Here’s what you need to do next.
The financial burden of drugs is impacting HIV-positive folks across America, and health insurance companies seem unfazed.
New medicines providing a better quality of life should always be top priority when asking for federal support.
